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Abstract
Background: Complex chromosome rearrangements (CCRs), which involve more than two
breakpoints on two or more chromosomes, are uncommon occurrences. Although most CCRs
appear balanced at the level of the light microscope, many demonstrate cryptic, submicroscopic
imbalances at the translocation breakpoints.
Results: We report a female with hearing loss and global developmental delay with a complex
three-way unbalanced translocation (5;20;8)(q31;p11.2;p21) resulting in microdeletions on 5q31.2,
5q31.3, and 8p23.2 identified by karyotyping, microarray analysis and fluorescence in situ
hybridization.
Discussion: The microdeletion of bands 8p23.2 may be associated with the hearing impairment.
Furthermore, the characterization of this patient's chromosomal abnormalities demonstrates the
importance of integrated technologies within contemporary cytogenetics laboratories.
Background
Reciprocal de novo translocations occur in about 1 in
2,000 newborns [1]. Although balanced translocations
are not often associated with abnormal phenotypes,
unbalanced translocations resulting in deleted or altered
gene sequences usually cause appreciable clinical features
[2,3]. Even more unusual than unbalanced translocations
are complex chromosome rearrangements (CCRs). CCRs
are structural abnormalities that involve more than two
breakpoints and exchange of genetic material between
two or more chromosomes [4,5]. The most common
CCRs involve three chromosomes with breakpoints on
each chromosome. The occurrence of three-way multiple
translocations is rare and often difficult to distinguish
from balanced translocations without the aid of addi-
tional diagnostic tools such as fluorescence in situ hybrid-
ization (FISH) [6] or microarray-based comparative
genomic hybridization (array CGH) [7,8].
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Molecular Cytogenetics 2009, 2:2 http://www.molecularcytogenetics.org/content/2/1/2We report on an 8-month-old female with hearing loss,
global developmental delay and myopathic face in whom
we found a de novo complex translocation (5;20;8)
(q31;p11.2;p21) and three microdeletions del(5)
(q31.2q31.2), del(5)(q31.3q32) and del(8)(p23.2) iden-
tified by traditional and molecular cytogenetic methods.
Case presentation
The proband is an 8-month-old female who was referred
for global developmental delay and hearing loss. She was
born at term by cesarean section to a 31-year-old mother.
The proband's birth weight was 4 kg (90th centile) and her
length was 48 cm (25th centile). The mother reports that
she did not drink alcohol, smoke cigarettes, or use any
unusual medications during the pregnancy. The father of
the proband was 32 years old with no prior family history
of congenital abnormalities.
At examination at 5 months of age, the patient was 6.6 kg
(<50th centile), 61 cm in length (<25th centile), with a
head circumference of 41.5 cm (50th centile). An Auditory
Brainstem Response test revealed bilateral mild sen-
sorineural hearing loss. An MRI of the brain revealed
white matter loss with thinning of the corpus callosum.
Upon physical examination, the patient displayed minor
dysmorphic features including a myopathic face (Fig 1).
No other remarkable dysmorphic features or observable
anomalies were noted.
Results
GTW-band analysis of the proband's peripheral blood
showed a CCR with an apparent deletion on chromosome
5. The karyotype was determined to be
46,XX,t(5;20;8)(q31;p11;p21),del(5)(q31.3q33.1) (Fig.
2a). Microarray analysis demonstrated a single-copy loss
of two regions on 5q: a two-BAC clone loss at 5q31.2
~240 kb in size (CTD-2015J11 – RP11-264B21) and a
nine-BAC clone loss at 5q31.3q32 (RP11-454M24 –
RP11-436M5) of 4.1 Mb in size. The regions of copy-
number loss were separated by 4 Mb of normal interven-
ing sequence. Microarray analysis also demonstrated a
single-copy loss of nine BACs at 8p23.2 (RP11-34M12 –
CTD-2340K13) 1.5 Mb in size.
FISH was performed to confirm the results of the microar-
ray analysis. A BAC clone from the deleted 5q31.2 region
(RP11-264B21) showed a diminished signal on the short
arm of the abnormal derivative chromosome 20 and no
signal on the derivative 5, suggesting the BAC contains the
breakpoint of the 5q31.2 deletion. The probe from the
non-deleted region between the two 5q31 deletions
(RP11-166J22) also hybridized to the der 20, as did a
probe to the 8p22 region (RP11-447G11).
FISH using BAC clones from the deleted 5q31.3 region
(RP11-1104L21) and the deleted 8p32.2 region (RP11-
1148N20) confirmed the deletions at 5q31.3 and 8p23.2,
respectively. The 5q telomeric probe (RP11-69N15) was
used as a control, and it showed hybridization to the der
20. The 20p telomeric probe (RP11-530N10) was used as
a second control, and it showed hybridization on the
short arm of the abnormal derivative 8. The 8p telomeric
probe (RP11-412M23) was used as a third control and
hybridized to the long arm of the derivative 5.
Thus, this individual has a three-way complex transloca-
tion between the long arm of chromosome 5, the short
arm of chromosome 20 and the short arm of chromo-
some 8 resulting in three interstitial deletions at bands
5q31.2, 5q31.3, and 8p23.2 with respective deletion sizes
of approximately 240 kb, 4.1 Mb, and 1.5 Mb as estimated
by array CGH.
Discussion
We report the molecular and cytogenetic finding of a
patient with a complex chromosome rearrangement
involving 5q31, 20p11.2 and 8p21 resulting in microde-
letions of bands 5q31.2, 5q31.3, and 8p23.2. The
proband's phenotype is nondescript; global developmen-
tal delay and sensorineural hearing loss are associated
with many microdeletions including 1p36, 7q21.13-
q22.1, 11q25, and Xq21 [9-13]. Many genomic regions
are associated with hearing loss because of the complexity
of and number of genes involved in hearing development.
5q31.2, 5q31.3, and 8p23.2 may be potential regions of
the genome critical to hearing development. However,
abnormalities involving 5q are rarely associated with
hearing loss, with the exception of Treacher Collins syn-
drome, an autosomally dominant trait associated with
severe craniofacial malformation that maps to 5q32-
5q33.1 [14]. Because the patient has no familial history of
Treacher Collins or the characteristic facial features, this
Proband at 5 months of age (A,B) and 6 days of age (C)Figure 1
Proband at 5 months of age (A,B) and 6 days of age 
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this patient. The short arm of chromosome 8 may contain
one or more genes directly or indirectly involved in the
formation of functional hearing pathways. Masuda et al.
[15] and Devriendt et al. [16] report sensorineural hearing
loss in patients with 8p abnormalities proximal to the tel-
omere resulting in partial 8p monosomy similar in size
and location to the deletion in our patient. In contrast,
Fryns et al. [17], Hutchinson et al. [18], and Devriendt et
al. [19] report patients with deletions of 8p23.1pter with-
out noting sensioneural hearing loss. CMSD1 is the only
known gene in the 1.5 Mb region on 8p23.2 deleted in
this individual. The deletion of CMSD1 has not been
directly implicated in sensorineural hearing loss or a sim-
ilar phenotype, but CMSD1 is known to play a role in neu-
ronal migration and development of the central nervous
system [20]. The deletion may be causing a position effect
on the chromosome and may play a role in the proband's
phenotype, either because the chromosomal rearrange-
ment separated a promoter from its transcriptional regu-
latory element, resulting in gene silencing; the
rearrangement juxtaposed a gene with an enhancer from
another gene, leading to inappropriate gene expression; or
the rearrangement moved a gene and its regulatory ele-
ments to a region of the genome that is transcriptionally
silent, such as heterochromatin. Alternatively, the translo-
cation breakpoints may have interrupted a gene or genes.
The ascertainment of additional individuals with similar
rearrangement breakpoints on 8p23.2 is necessary for fur-
ther genotype-phenotype correlation.
Because of the complexity of the CCR, none of the tech-
nologies could accurately confirm the de novo complex
CCR independently. Two of the microdeletions initially
went undetected by traditional cytogenetic analysis,
which is consistent with previous research on CCRs
Summary of characterization of t(5;20;8)(q31;p11.2;p21)Figure 2
Summary of characterization of t(5;20;8)(q31;p11.2;p21). (A) Karyotype results for the patient; note the abnormal 
chromosome 20. (B) Microarray results showing complex rearrangement of 5q. The top plot shows a normal chromosome 5; 
the bottom plot shows the abnormal chromosome 5. Each clone represented on the array is arranged along the x-axis accord-
ing to its location on the chromosome with the most distal/telomeric p-arm clones on the left and the most distal/telomeric q-
arm clones on the right. The blue line plots represent the ratios from the first experiment for the case (control Cy5/patient 
Cy3) and the pink plots represent the ratios obtained from the second experiment for the case in which the dyes have been 
reversed (patient Cy5/control Cy3). (C) Microarray results showing deletion of 8p23.2. Microarray plots are arranged as in B 
from pter to qter. (D) FISH results for 5q31.2 (red), 5q tel (green) and 20 cen (green). (E) Locations on the derivative chromo-
some of 8p22 (red), 5q tel (green), and 20 cen (green).Page 3 of 5
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breakpoints by microarray analysis was it possible to
determine the location and order of the de novo CCR
within the patients' genome using the appropriate FISH
probes to locate the translocated sections of chromo-
somes 8p and 5q. Our results suggest the successful inte-
gration of multiple cytogenetic techniques–karyotyping,
aCGH, and FISH – is necessary in the diagnostic labora-




Cytogenetic analysis was performed on peripheral blood
lymphocytes by G-banding according to standard proce-
dures.
BAC array CGH
Array CGH was performed with a bacterial artificial chro-
mosome (BAC) microarray (the SignatureChip®; Signa-
ture Genomic Laboratories, Spokane, WA) that was
developed for the detection of microdeletions, microdu-
plications, aneuploidy, unbalanced translocations, and
subtelomeric and pericentromeric copy-number altera-
tions [22]. The current version of the SignatureChip, the
SignatureChip Whole Genome™ (SignatureChipWG),
contains 4670 BACs representing 1543 loci with each
locus being represented by a minimum of three overlap-
ping clones. The subtelomeric and pericentromeric
regions are represented with a higher density of overlap-
ping BAC clones, targeted to the unique sequences adja-
cent to these repetitive regions and consist of contigs of
clones located approximately every 0.5 Mb spanning
more than 5 Mb. Genes in important developmental
pathways are also covered by contigs of BACs to fill in the
chromosome arms and provide higher resolution with an
average gap size between contigs of ~1.6 Mb [22].
Microarray analysis was performed as described [22], with
the following modifications: Briefly, genomic DNA was
extracted from peripheral blood using a Qiagen M48
Biorobot automated DNA extraction system. Purified
genomic DNA was then sonicated and labeled with Alex-
aflour dyes 555 or 647 using a BioPrime Total DNA labe-
ling kit (Invitrogen Corp). Microarrays were hybridized as
previously described (8) and washed using a Little Dipper
automated microarray washing station (SciGene). Micro-
arrays were scanned on an Axon 4000B scanner (Molecu-
lar Devices) and signal intensity ratios were analyzed as
described (8) using a custom analysis and display inter-
face (Genoglyphix™).
FISH
All abnormalities detected by array CGH were confirmed
and visualized by metaphase or interphase fluorescence in
situ hybridization (FISH) using one or more BAC clones
determined to be abnormal by array CGH [23].
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